Correlation Between Oric Pharmaceuticals and Rezolute
Can any of the company-specific risk be diversified away by investing in both Oric Pharmaceuticals and Rezolute at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oric Pharmaceuticals and Rezolute into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oric Pharmaceuticals and Rezolute, you can compare the effects of market volatilities on Oric Pharmaceuticals and Rezolute and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oric Pharmaceuticals with a short position of Rezolute. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oric Pharmaceuticals and Rezolute.
Diversification Opportunities for Oric Pharmaceuticals and Rezolute
-0.02 | Correlation Coefficient |
Good diversification
The 3 months correlation between Oric and Rezolute is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Oric Pharmaceuticals and Rezolute in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rezolute and Oric Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oric Pharmaceuticals are associated (or correlated) with Rezolute. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rezolute has no effect on the direction of Oric Pharmaceuticals i.e., Oric Pharmaceuticals and Rezolute go up and down completely randomly.
Pair Corralation between Oric Pharmaceuticals and Rezolute
Given the investment horizon of 90 days Oric Pharmaceuticals is expected to generate 4.52 times less return on investment than Rezolute. But when comparing it to its historical volatility, Oric Pharmaceuticals is 1.24 times less risky than Rezolute. It trades about 0.01 of its potential returns per unit of risk. Rezolute is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 354.00 in Rezolute on September 18, 2024 and sell it today you would earn a total of 90.00 from holding Rezolute or generate 25.42% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Oric Pharmaceuticals vs. Rezolute
Performance |
Timeline |
Oric Pharmaceuticals |
Rezolute |
Oric Pharmaceuticals and Rezolute Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Oric Pharmaceuticals and Rezolute
The main advantage of trading using opposite Oric Pharmaceuticals and Rezolute positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oric Pharmaceuticals position performs unexpectedly, Rezolute can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rezolute will offset losses from the drop in Rezolute's long position.Oric Pharmaceuticals vs. Seer Inc | Oric Pharmaceuticals vs. Anebulo Pharmaceuticals | Oric Pharmaceuticals vs. Cullinan Oncology LLC | Oric Pharmaceuticals vs. C4 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
CEOs Directory Screen CEOs from public companies around the world | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum |